Last update 21 Nov 2024
Enavogliflozin/METFORMIN HYDROCHLORIDE
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Envlomet, Envlomet SR Tab., Envolomet + [3] |
Target |
Mechanism PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC24H27ClO6 |
InChIKeyKORCWPOBTZTAFI-YVTYUBGGSA-N |
CAS Registry1415472-28-4 |
View All Structures (2)
Related
2
Clinical Trials associated with Enavogliflozin/METFORMIN HYDROCHLORIDEAn Anonymized, De-identified Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
A Crossover, Randomized, Open-label, Comparison Study Between DWJ1525 and the Concomitant Use of DWP16001 and DWC202101 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
100 Clinical Results associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
Login to view more data
100 Translational Medicine associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
Login to view more data
100 Patents (Medical) associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
Login to view more data
100 Deals associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
Login to view more data
R&D Status
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free